University of Sharjah Report issue

Academic/Hospital Phase 4
Founded: Sharjah United Arab Emirates (1997)

Organization Overview

First Clinical Trial
2019
NCT03883685
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Alya Abdelghafour Alkhajeh | University of Sharjah

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Endotoxemia (Phase 4)

Inflammation (Phase 4)

Metabolic Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 4